Megan Adediran/ LinkedIn
Mar 3, 2026, 08:48
Megan Adediran: Redefining Rare Diseases in Nigeria’s Healthcare System
Megan Adediran, Executive Director of the Haemophilia Foundation of Nigeria, shared a post on LinkedIn:
“How Rare Is Rare?
A disease is called rare when it affects a small number of people. But there are over 7,000 rare diseases.
Together, they affect more than 300 million people worldwide.
That is not rare. That is a movement.
In Nigeria, rare often means:
- Late diagnosis.
- Limited treatment.
- High costs.
- Silent suffering.
For people living with haemophilia and other rare conditions, awareness can mean the difference between disability and dignity.
Rare is not invisible. Rare is not insignificant. Rare is someone’s child. Rare should never mean forgotten.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia